Oncologic outcome of colon cancer with perforation and obstruction

BMC Gastroenterol. 2022 May 15;22(1):247. doi: 10.1186/s12876-022-02319-5.

Abstract

Purpose: Perforation and obstruction in colorectal cancer are poor prognostic factors. We aimed to evaluate the oncological outcomes of patients with colon cancer presenting with perforation or obstruction.

Methods: A total of 260 patients underwent surgery for colon cancer between January 2015 and December 2017. Among them, 54 patients who underwent emergency surgery for perforated (n = 32) or obstructive (n = 22) colon cancer were included.

Results: The perforation (PG, n = 32) and obstruction groups (OG, n = 22) did not differ significantly in age (p = 0.486), sex (p = 0.821), tumor stage (p = 0.221), tumor location (p = 0.895), histologic grade (p = 0.173), or 3-year overall survival rate (55.6% vs. 50.0%, p = 0.784). However, the PG had a higher postoperative complication rate (44% vs. 17%, p = 0.025), longer intensive care unit stay (4.8 days vs. 0.8 days, p = 0.047), and lower 3-year recurrence-free survival (42.4% vs. 78.8%, p = 0.025) than the OG. In the multivariate analysis, perforation was significantly increased risk of recurrence (hazard ratio = 3.67, 95% confidence interval: 1.049-12.839, p = 0.042).

Conclusion: Patients with colon cancer initially presenting with perforation had poorer recurrence-free survival, higher postoperative complication rates, and longer ICU stays than those who had obstruction.

Keywords: Colon cancer; Obstruction; Oncologic outcome; Perforation; Survival.

MeSH terms

  • Colonic Neoplasms* / complications
  • Colonic Neoplasms* / surgery
  • Humans
  • Intestinal Obstruction* / etiology
  • Intestinal Obstruction* / surgery
  • Intestinal Perforation* / etiology
  • Intestinal Perforation* / surgery
  • Postoperative Complications / epidemiology
  • Proportional Hazards Models
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome